Linklaters advised Impact Investment Exchange (IIX), a Singapore-based impact investor, on the issuance of its US$52.8m Women’s Livelihood Bond (WLB7), the latest in the pioneering series designed to support women’s
Linklaters advised Impact Investment Exchange (IIX), a Singapore-based impact investor, on the issuance of its US$52.8m Women’s Livelihood Bond (WLB7), the latest in the pioneering series designed to support women’s
Ropes & Gray is representing an ad hoc group of secured lenders and certain DIP lenders in connection with Maverick Gaming’s chapter 11 cases filed on July 14, 2025. Maverick
Ropes & Gray represented Singapore-based biotechnology company Gero PTE. LTD. in a joint research and license agreement with Tokyo-based Chugai Pharmaceutical Co, Ltd., a member of Roche Group, to develop
Kirkland & Ellis advised Silversmith Capital Partners, a growth equity firm focused on supporting the best entrepreneurs in technology and healthcare, in connection with the first and final close of
In today’s data-driven world, trucking accidents are no longer reconstructed solely through eyewitness accounts or skid marks—they’re decoded through black boxes, dashcams, and satellite telemetry. As commercial vehicles evolve into
Global law firm Clifford Chance has advised a syndicate of lenders (comprising BBVA, BNP Paribas and Commerzbank) and SACE, the Italian insurance and financial group, on a €500 million facility
Dentons has advised Develia developer on the sale of the Arkady Wrocławskie shopping center to Vastint Poland, a company developing commercial projects in key regional cities across Poland. The disposal
Dentons is pleased to announce the closing of an Initial Public Offering (“IPO”) for C1 Fund Inc. Dentons Venture Technology, Capital Markets and Fund Compliance teams advised C1 Fund on
Transporting a vehicle from one state to another, such as interstate auto transport, can be daunting for anyone who has never done it. But there are ways to make it
Ropes & Gray represented the underwriters in Rhythm Pharmaceuticals’ (Nasdaq: RYTM) $201 million equity offering, including the full exercise of the underwriters’ $26 million option to purchase additional shares. The